Acute Glomerulonephritis Following Systemic Scabies in Two Brothers

Overview

Journal Children (Basel)

Specialty Health Services

Date 2024 Aug 29

PMID 39201916

Authors

Flavia Chisavu

Mihai Gafencu

Ruxandra Maria Steflea

Adrian Vaduva

Floriana Izvernariu

Ramona Florina Stroescu

Affiliations

Soon will be listed here.

Abstract

Scabies is a parasitic infestation of the skin with high prevalence in crowded spaces. In some instances, scabies becomes the underlying factor for complicated skin-borne opportunistic pathogens infections in both children and adults. Geographic area and socio-economic factors are determinants of the endemic pattern of this disease. Currently, the treatment of scabies has been under special attention. A combination of oral therapy with Ivermectin and sulfur-based ointments are the gold standard. However, caution is required in patients with kidney impairment. The renal involvement in children with scabies is mainly caused by acute glomerulonephritis. The severity of the nephritic syndrome can lead to other complications. Also, Ivermectin possesses a nephrotoxic effect. Severe hypertension can lead to neurological complications. The aim of our case report is to present two unusual complications in brothers with scabies. We report the cases of two brothers with scabies who presented with severe skin infection that developed acute post infectious glomerulonephritis (APIGN). In addition, one of the brothers presented with posterior reversible encephalopathy syndrome (PRES). The other one developed acute tubule-interstitial acute kidney injury following Ivermectin administration. The evolution of skin lesions was favorable, and kidney function returned to normal in both brothers.

References

Dhana A, Yen H, Okhovat J, Cho E, Keum N, Khumalo N . Ivermectin versus permethrin in the treatment of scabies: A systematic review and meta-analysis of randomized controlled trials. J Am Acad Dermatol. 2017; 78(1):194-198. DOI: 10.1016/j.jaad.2017.09.006. View

Salman M, Abbas R, Mehmood K, Hussain R, Shah S, Faheem M . Assessment of Avermectins-Induced Toxicity in Animals. Pharmaceuticals (Basel). 2022; 15(3). PMC: 8950826. DOI: 10.3390/ph15030332. View

Fischer M, Schmutzhard E . Posterior reversible encephalopathy syndrome. J Neurol. 2017; 264(8):1608-1616. PMC: 5533845. DOI: 10.1007/s00415-016-8377-8. View

Heukelbach J, Walton S, Feldmeier H . Ectoparasitic infestations. Curr Infect Dis Rep. 2005; 7(5):373-80. DOI: 10.1007/s11908-005-0012-2. View

Wu M, Li C, Pan H, Lin Y . The Relationship between Scabies and Stroke: A Population-Based Nationwide Study. Int J Environ Res Public Health. 2019; 16(18). PMC: 6766212. DOI: 10.3390/ijerph16183491. View

Chaturvedi S, Boyd R, Krause V . Acute Post-Streptococcal Glomerulonephritis in the Northern Territory of Australia: A Review of Data from 2009 to 2016 and Comparison with the Literature. Am J Trop Med Hyg. 2018; 99(6):1643-1648. PMC: 6283515. DOI: 10.4269/ajtmh.18-0093. View

WHITE A, Hoy W, McCREDIE D . Childhood post-streptococcal glomerulonephritis as a risk factor for chronic renal disease in later life. Med J Aust. 2001; 174(10):492-6. DOI: 10.5694/j.1326-5377.2001.tb143394.x. View

Faille L, Fieuws S, Van Paesschen W . Clinical predictors and differential diagnosis of posterior reversible encephalopathy syndrome. Acta Neurol Belg. 2017; 117(2):469-475. PMC: 5440491. DOI: 10.1007/s13760-017-0750-6. View

Bergstrom F, Reynolds S, Johnstone M, Pike R, Buckle A, Kemp D . Scabies mite inactivated serine protease paralogs inhibit the human complement system. J Immunol. 2009; 182(12):7809-17. DOI: 10.4049/jimmunol.0804205. View

10.

Sorger K, GESSLER U, Hubner F, Kohler H, Schulz W, Stuhlinger W . Subtypes of acute postinfectious glomerulonephritis. Synopsis of clinical and pathological features. Clin Nephrol. 1982; 17(3):114-28. View

11.

Chowdhary M, Kabbani A, Tobey D, Hope T . Posterior reversible encephalopathy syndrome in a woman with focal segmental glomerulosclerosis. Neuropsychiatr Dis Treat. 2015; 11:1111-4. PMC: 4411014. DOI: 10.2147/NDT.S84010. View

12.

Richards R . Scabies: Diagnostic and Therapeutic Update. J Cutan Med Surg. 2020; 25(1):95-101. DOI: 10.1177/1203475420960446. View

13.

Hardy M, Samuela J, Kama M, Tuicakau M, Romani L, Whitfeld M . The safety of combined triple drug therapy with ivermectin, diethylcarbamazine and albendazole in the neglected tropical diseases co-endemic setting of Fiji: A cluster randomised trial. PLoS Negl Trop Dis. 2020; 14(3):e0008106. PMC: 7098623. DOI: 10.1371/journal.pntd.0008106. View

14.

Hay R, Steer A, Engelman D, Walton S . Scabies in the developing world--its prevalence, complications, and management. Clin Microbiol Infect. 2012; 18(4):313-23. DOI: 10.1111/j.1469-0691.2012.03798.x. View

15.

Rosumeck S, Nast A, Dressler C . Ivermectin and permethrin for treating scabies. Cochrane Database Syst Rev. 2018; 4:CD012994. PMC: 6494415. DOI: 10.1002/14651858.CD012994. View

16.

Mounsey K, Bernigaud C, Chosidow O, McCarthy J . Prospects for Moxidectin as a New Oral Treatment for Human Scabies. PLoS Negl Trop Dis. 2016; 10(3):e0004389. PMC: 4795782. DOI: 10.1371/journal.pntd.0004389. View

17.

Mika A, Reynolds S, Pickering D, McMillan D, Sriprakash K, Kemp D . Complement inhibitors from scabies mites promote streptococcal growth--a novel mechanism in infected epidermis?. PLoS Negl Trop Dis. 2012; 6(7):e1563. PMC: 3398963. DOI: 10.1371/journal.pntd.0001563. View

18.

Dieng M, Ndiaye B, Ndiaye A . [Scabies complicated by acute glomerulonephritis in children: 114 cases observed in two years in a pediatric service in Dakar]. Dakar Med. 2000; 43(2):201-4. View

19.

Bernigaud C, Fang F, Fischer K, Lespine A, Aho L, Mullins A . Efficacy and Pharmacokinetics Evaluation of a Single Oral Dose of Afoxolaner against Sarcoptes scabiei in the Porcine Scabies Model for Human Infestation. Antimicrob Agents Chemother. 2018; 62(9). PMC: 6125498. DOI: 10.1128/AAC.02334-17. View

20.

Bernigaud C, Samarawickrama G, Jones M, Gasser R, Fischer K . The Challenge of Developing a Single-Dose Treatment for Scabies. Trends Parasitol. 2019; 35(11):931-943. DOI: 10.1016/j.pt.2019.08.002. View